Press Releases
🇺🇸 FDA Page 14FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 157–168 of 212 articles
Outlook Therapeutics Completes FDA Dispute Resolution Meeting for LYTENAVA Bevacizumab Biosimilar
Follicular Lymphoma Clinical Trials Surge: 45+ Companies Developing New Treatments in 2026
IceCure Medical ProSense Revenue Surges 30% in Q1 2026 as Cryoablation Technology Gains Traction
Nuvalent to Present Pivotal Neladalkib Data from ALKOVE-1 Trial at ASCO 2026 for ALK-Positive Lung Cancer
FDA Approves Merck's IDVYNSO: First Non-INSTI, Tenofovir-Free Two-Drug HIV Treatment
LENZ Therapeutics Submits VIZZ Presbyopia Treatment for UK Approval Following EU Validation
Pasithea Therapeutics' PAS-004 Receives FDA Rare Pediatric Disease Designation for Neurofibromatosis Type 1 Treatment
Clearmind Medicine CMND-100 Meets Primary Safety Endpoint in Alcohol Use Disorder Trial
Sapience Therapeutics ST316 Shows 47% Response Rate in Phase 2 Colorectal Cancer Trial
Abogen's ABO2203 mRNA Cancer Therapy Shows Promise in First-in-Human B-Cell Lymphoma Trial at AACR 2026
Inhibrx Biosciences to Present Ozekibart (INBRX-109) Clinical Data for Late-Line Colorectal Cancer Treatment
Debiopharm's Lunresertib Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Cancer Treatment